These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. New insights for precision treatment of glioblastoma from analysis of single-cell lncRNA expression. Meng Q; Zhang Y; Li G; Li Y; Xie H; Chen X J Cancer Res Clin Oncol; 2021 Jul; 147(7):1881-1895. PubMed ID: 33693962 [TBL] [Abstract][Full Text] [Related]
3. A 35-gene signature discriminates between rapidly- and slowly-progressing glioblastoma multiforme and predicts survival in known subtypes of the cancer. Fatai AA; Gamieldien J BMC Cancer; 2018 Apr; 18(1):377. PubMed ID: 29614978 [TBL] [Abstract][Full Text] [Related]
9. A novel gene signature based on five glioblastoma stem-like cell relevant genes predicts the survival of primary glioblastoma. Chai R; Zhang K; Wang K; Li G; Huang R; Zhao Z; Liu Y; Chen J J Cancer Res Clin Oncol; 2018 Mar; 144(3):439-447. PubMed ID: 29299749 [TBL] [Abstract][Full Text] [Related]
10. Biobanking: An Important Resource for Precision Medicine in Glioblastoma. Tan SY; Sandanaraj E; Tang C; Ang BT Adv Exp Med Biol; 2016; 951():47-56. PubMed ID: 27837553 [TBL] [Abstract][Full Text] [Related]
11. A three ion channel genes-based signature predicts prognosis of primary glioblastoma patients and reveals a chemotherapy sensitive subtype. Wang HY; Li JY; Liu X; Yan XY; Wang W; Wu F; Liang TY; Yang F; Hu HM; Mao HX; Liu YW; Zhang SZ Oncotarget; 2016 Nov; 7(46):74895-74903. PubMed ID: 27713134 [TBL] [Abstract][Full Text] [Related]
12. Association between SNAP25 and human glioblastoma multiform: a comprehensive bioinformatic analysis. Yu C; Yin J; Wang X; Chen L; Wei Y; Lu C; You Y Biosci Rep; 2020 Jun; 40(6):. PubMed ID: 32412599 [TBL] [Abstract][Full Text] [Related]
13. Aurora kinase A as a rational target for therapy in glioblastoma. Barton VN; Foreman NK; Donson AM; Birks DK; Handler MH; Vibhakar R J Neurosurg Pediatr; 2010 Jul; 6(1):98-105. PubMed ID: 20593995 [TBL] [Abstract][Full Text] [Related]
14. Expression of interleukin-13 receptor alpha2 in glioblastoma multiforme: implications for targeted therapies. Jarboe JS; Johnson KR; Choi Y; Lonser RR; Park JK Cancer Res; 2007 Sep; 67(17):7983-6. PubMed ID: 17804706 [TBL] [Abstract][Full Text] [Related]
15. The Urokinase Receptor Induces a Mesenchymal Gene Expression Signature in Glioblastoma Cells and Promotes Tumor Cell Survival in Neurospheres. Gilder AS; Natali L; Van Dyk DM; Zalfa C; Banki MA; Pizzo DP; Wang H; Klemke RL; Mantuano E; Gonias SL Sci Rep; 2018 Feb; 8(1):2982. PubMed ID: 29445239 [TBL] [Abstract][Full Text] [Related]
16. Genomic landscape of glioblastoma and the potential clinical utility. Wang CJ; Choe KS CNS Oncol; 2014 May; 3(3):169-72. PubMed ID: 25055121 [No Abstract] [Full Text] [Related]
17. An eight-mRNA signature outperforms the lncRNA-based signature in predicting prognosis of patients with glioblastoma. Gong Z; Hong F; Wang H; Zhang X; Chen J BMC Med Genet; 2020 Mar; 21(1):56. PubMed ID: 32188434 [TBL] [Abstract][Full Text] [Related]
18. Studying a complex tumor: potential and pitfalls. Zheng S; Chheda MG; Verhaak RG Cancer J; 2012; 18(1):107-14. PubMed ID: 22290264 [TBL] [Abstract][Full Text] [Related]